Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Recognizing the Signs of TK2 Deficiency
Uncovering TK2d: How to Navigate Diagnostic Challenges
Immunologic Phenotyping: The Future of Personalized MG Care
The New Era of Targeted Therapy for Myasthenia Gravis
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Outcome Measures Capture Progression in Late-Onset TK2d
More Than a Myopathy: The Lived Experience of TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.